Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Work In Process (2020 - 2025)

IceCure Medical (ICCM) has disclosed Work In Process for 5 consecutive years, with $231000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Work In Process fell 26.9% to $231000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $231000.0, a 26.9% decrease, with the full-year FY2024 number at $231000.0, down 26.9% from a year prior.
  • Work In Process was $231000.0 for Q4 2024 at IceCure Medical, down from $316000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $457000.0 in Q4 2021 to a low of $231000.0 in Q4 2024.
  • A 5-year average of $338400.0 and a median of $332000.0 in 2020 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: soared 37.65% in 2021, then dropped 26.9% in 2024.
  • IceCure Medical's Work In Process stood at $332000.0 in 2020, then skyrocketed by 37.65% to $457000.0 in 2021, then dropped by 22.1% to $356000.0 in 2022, then fell by 11.24% to $316000.0 in 2023, then decreased by 26.9% to $231000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Work In Process are $231000.0 (Q4 2024), $316000.0 (Q4 2023), and $356000.0 (Q4 2022).